4th Annual Live Medical Crossfire® IBS and IBD
Released On
March 30, 2023
Expires On
March 30, 2024
Media Type
Internet
Completion Time
360 minutes
Specialty
Gastroenterology, Primary Care
Topic(s)
IBS, IBD
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Salix.
Credit Available
- Physicians — maximum of 6.0 AMA PRA Category 1 Credit(s)™
- Nurses — 6.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is primarily directed toward gastroenterologists and primary care physicians. Nurse practitioners, physician assistants, pharmacists, researchers, and other health care professionals involved in the treatment and management of IBS and IBD are invited to participate.
Program Overview
The management of patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) is challenging, and a personalized approach is required. To maintain a high level of care, clinicians must remain up to date on advances in the field. The 4th Annual Live Medical Crossfire®: IBS and IBD provides an unparalleled opportunity for clinicians to solidify best practices and evaluate new developments with leaders in gastroenterology. During this 2-day conference, which was designed to educate and empower clinicians who care for patients with IBS and IBD, leading clinician researchers discuss the application of data to clinical practice.
This educational activity is an archive of the live virtual symposium held on February 24-25, 2023.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize the guideline-recommended criteria and testing procedures needed to make an early, accurate diagnosis of IBS or IBD
- Apply current guideline recommendations to the pharmacological and non-pharmacological management of patients with IBS or IBD
- Assess clinical evidence for the efficacy and safety of biologic and nonbiologic agents used in the management of IBS or IBD
- Develop individualized short- and long-term treatment plans that optimally manage IBS or IBD to improve patient outcomes and health-related quality of life
Faculty
Anita Afzali, MD, MPH, MHCM, FACG, AGAF
Professor of Medicine
Division of Digestive Diseases
Executive Vice Chair of Medicine
Department of Internal Medicine
University of Cincinnati College of Medicine
Associate Chief Medical Officer
UC Health System
Cincinnati, OH
William D. Chey, MD, AGAF, FACG, FACP, RFF
H. Marvin Pollard Professor of Gastroenterology
Chief, Division of Gastroenterology and Hepatology
Professor, Department of Nutritional Sciences
Michigan Medicine
Ann Arbor, MI
Bruce E. Sands, MD, MS
Dr Burrill B. Crohn Professor of Medicine
Chief of the Dr Henry D. Janowitz Division of Gastroenterology
Mount Sinai Hospital
Chief, Division of Gastroenterology
Mount Sinai Health System
Director, Digestive Disease Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Bincy Abraham, MD, MS, AGAF, FACG, FASGE
Professor of Clinical Medicine, Houston Methodist Academic Institute
Professor of Clinical Medicine, Weill Cornell Medical College
Adjunct Associate Professor of Internal Medicine, Texas A&M University, College of Medicine
Director, Gastroenterology Fellowship Program, Houston Methodist
Distinguished Professor and Director, Underwood Center – Fondren Inflammatory Bowel Disease Program
Houston Methodist Gastroenterology Associates
Houston, TX
Jordan Axelrad, MD, MPH
Director, Clinical and Translational Research
Inflammatory Bowel Disease Center at NYU Langone Health
Assistant Professor of Medicine
NYU Grossman School of Medicine
New York, NY
Abhik Bhattacharya, MD
Assistant Professor of Medicine
The Susan and Leonard Feinstein IBD Center
The Dr. Henry J. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai
New York, NY
Lin Chang, MD
Professor of Medicine
Vice-Chief, Vatche and Tamar Manoukian Division of Digestive Diseases
David Geffen School of Medicine at UCLA
Los Angeles, CA
Lucinda Harris, MS, MD
Professor of Medicine
Division of Gastroenterology & Hepatology
Mayo Clinic – Alix School of Medicine
Scottsdale, AZ
Sunanda V. Kane, MD, MSPH
Professor of Medicine
Departments of Gastroenterology and Hepatology
Mayo Clinic Rochester
Rochester, MN
Ali Rezaie, MD, MSc, FRCPC
Medical Director, GI Motility Program
Director of Bioinformatics, Medically Associated Science and Technology (MAST) Program
Program Director, Advanced GI Motility Fellowship
Associate Professor, Cedars-Sinai
Associate Clinical Professor, UCLA
Associate Editor, Digestive Disease and Sciences
Los Angeles, CA
Megan E. Riehl, PsyD
GI Psychologist
Assistant Clinical Professor of Medicine
University of Michigan
Ann Arbor, MI
Kate Scarlata, MPH, RDN
GI Dietician
For a Digestive Peace of Mind, LLC
Medway, MA
Kyle Staller, MD, MPH
Director, Gastrointestinal Motility Laboratory, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School
Massachusetts General Hospital and Harvard Medical School
Boston, MA
Thomas A. Ullman, MD
Chief, Division of Gastroenterology
Professor of Medicine
Montefiore Medical Center
Albert Einstein College of Medicine
Bronx, NY
Zoë Gottlieb, MD
Assistant Professor of Medicine
Icahn School of Medicine at the Mount Sinai Hospital
New York, NY
Eric Shah, MD, MBA, FACG
Director
Center for Gastrointestinal Motility, Esophageal, and Swallowing Disorders
Assistant Professor of Medicine and The Dartmouth Institute
Dartmouth Hitchcock Medical Center
Lebanon, NH
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 6.0 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.
- Anita Afzali, MD, MPH, MHCM, FACG, AGAF
- Grant/Research Support: Abbvie Inc, Bristol Myers Squibb, Janssen, Takeda
- Consultant: Abbvie Inc, Celgene Corporation, Janssen, Pfizer Inc, Takeda
- Other: IBD Horizons
- William D. Chey, MD, AGAF, FACG, FACP, RFF
- Grant/Research Support: Biomerica Inc, Commonwealth Diagnostics International, QOL Medical, Urovant Sciences, Vibrant Pharma
- Consultant: Biomerica, Ironwood Pharmaceuticals, QOL Medical, Ritter Pharmaceuticals, Salix Pharmaceuticals/Valeant Pharmaceuticals International, Takeda, Urovant Sciences, Vibrant Pharma
- Shareholder: Modify Health, Ritter Pharmaceuticals
- Bruce E. Sands, MD, MS
- Grant/Research Support: Arena Pharmaceuticals, Bristol Myers Squibb, Janssen
- Consultant: AbbVie, Amgen, Arena Pharmaceuticals, AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Celltrion, Eli Lilly and Company, Fresenius Kabi, Genentech, GSK, Janssen, Merck & Co, Pfizer, Sun Pharmaceutical Industries Limited, Takeda, Teva Pharmaceuticals
- Speaker’s Bureau: Ventyx Biosciences
- Bincy Abraham, MD, MS, AGAF, FACG, FASGE
- Grant/Research Support: Takeda
- Consultant: Abbvie Inc, Bristol Myers Squibb, Eli Lilly and Company, Fresenius Kabi, Janssen, Pfizer Inc, Samsung Bioepis Co, Takeda
- Speaker’s Bureau: Abbvie Inc, Bristol Myers Squibb, Janssen, Pfizer Inc.
- Jordan Axelrad, MD, MPH
- Consultant: Abbvie, Adiso Therapeutics, Bristol Myers Squibb, Janssen, Pfizer
- Abhik Bhattacharya, MD
- Site PI for CHASE-EIM study funded by Crohn's and Colitis Foundation of America
- Site PI for GRASP-IBD study funded by Spondyloarthritis Association of America
- Lin Chang, MD
- Grant/Research Support: Arena Pharmaceuticals, AnX Robotica Corporation, Ironwood Pharmaceuticals, Vanda Pharmaceuticals
- Consultant: Arena Pharmaceuticals, Immunic, Ironwood Pharmaceuticals, Mauna Kea Technologies, Salix Pharmaceuticals (Bausch Health Companies), Trellus Health
- Speaker’s Bureau: Ironwood Pharmaceuticals
- Shareholder: Modify Health, Trellus Health
- Other: Royalties: Rome Foundation
- Lucinda Harris, MS, MD
- Grant/Research Support: Takeda
- Consultant: AbbVie, Alnylam Pharmaceuticals, Ardelyx, Gemelli Biotech Corp, Ironwood Pharmaceuticals, Rome Foundation
- Sunanda V. Kane, MD, MSPH
- Grant/Research Support: Bristol Myers Squibb
- Consultant: Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly and Company, Fresenius Kabi, Gilead Sciences, InveniAI, Janssen, Pfizer, Seres Therapeutics, Takeda, TechLab
- Other: Editor for UpToDate
- Ali Rezaie, MD, MSc, FRCPC
- Consultant: Alnylam Pharmaceuticals, Ardelyx, Bausch Health Companies
- Speaker’s Bureau: Bausch Health Companies
- Other: Equity: BetterBiome, Gemelli Biotech Corp
- Megan E. Riehl, PsyD
- Consultant: GI OnDEMAND LLC, a joint partnership of Gastro Girl, Inc, and the American College of Gastroenterology
- Kate Scarlata, MPH, RDN
- Grant/Research Support: Belli Welli Inc; Commonwealth Diagnostics International, Inc; Fody Food Co; GI OnDEMAND LLC, a joint partnership of Gastro Girl, Inc, and the American College of Gastroenterology; QOL Medical, LLC; Mahana Therapeutics
- Speaker’s Bureau: Fody Food Co; Epicured Meal Delivery, LLC.
- Kyle Staller, MD, MPH
- Grant/Research Support: Ironwood Pharmaceuticals, Urovant Sciences
- Consultant: Anji Pharmaceuticals, Ardelyx, Arena Pharmaceuticals, Gelesis Holdings, GI Supply, Restalsis, Sanofi, Takeda
- Thomas A. Ullman, MD
- Consultant: Pfizer Inc.
- Zoë Gottlieb, MD
- Grant/Research Support: Janssen, Pfizer Inc.
- Eric Shah, MD, MBA, FACG
- Consultant: Ardelyx, GI Supply, Mahana Therapeutics, NeurAxis, Salix Pharmaceuticals, Takeda
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
You may immediately download your certificate.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.